Biocytogen
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
50c Audubon Rd, Wakefield, Massachusetts...Phone Number
(781) 587-3558Website
www.biocytogen.comRevenue
$488.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
3
1
1
About Biocytogen
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is a global biotechnology company that drives the research and development of novel antibody-based therapeutics. The company has streamlined the drug development process through the use of RenMice for fully human antibody discovery, in vivo drug efficacy screening platforms and strong clinical development expertise. Biocytogens RenMice HiTS Platform aims to develop novel antibody drugs with first-in-class and/or best-in-class potential for more than 1000 targets, and has resulted in collaborations with dozens of partners worldwide. The company's pipeline includes 12 core products; two products are in phase II MRCTs and two products are in phase I. Headquartered in Beijing, Biocytogen has branches in Haimen Jiangsu, Shanghai, Boston, USA and Heidelberg, Germany.Explore more
Biocytogen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biocytogen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Biocytogen
Earning: See what the market has to say on Biocytogen recently announced quarterly report
Check if Biocytogen has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Biocytogen had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Biocytogen has new funding data
Product Launch: Get notified when Biocytogen launches new products
Website visits: Recent activity has been detected on your website
Biocytogen, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Biocytogen is spiking on competitors!
Recommended Actions
Find VP level buyers at Biocytogen
Find more new buyers
Compare Similar Companies to Biocytogen
Compare insights from companies similar to Biocytogen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Biocytogen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Biocytogen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Biocytogen.
Biocytogen financials insights
Gather financial insights about Biocytogen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Stock Offering
$60M
Biocytogen Tech Stack
A closer look at the technologies used by Biocytogen
Most Recent Scoops
Event
Product Marketing, Events, Sales, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Person-Based
Research & Development, Pharmaceuticals
Person-Based
Medical Research, Pharmaceuticals
Hiring Plans
Hiring Plans
Biocytogen News & Media
Biocytogen lands on STAR as NASDAQ plays parlay data into cash: Finance Report
Several large follow-ons were completed in the past two weeks on the back of strong Phase III data, but a rare initial listing by a life sciences company o...Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development
BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a global licensing agreement with BeOne Medicines Ltd., a global oncology company, for multiple fully human antibodies. Prior to this licensing agreement, BeOne Medicines had obtained a license to use Biocytogen’s RenMice® fulBiocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development
BEIJING--(BUSINESS WIRE)-- #Antibody--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a global licensing agreement with BeOne Medicines Ltd., a global oncology company, for multiple fully human antibodies. Prior to this licensing agreement, BeOne Medicines had obtained a license to use Biocytogen’s RBiocytogen Secures Japan Patent for RenMab Platform, Expands Global Patent Portfolio for RenMice Fully Human Antibody/TCR Platform
BEIJING--(BUSINESS WIRE)-- #Antibody--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully human antibody mouse platform has been granted an invention patent by the Japan Patent Office (JPO). This milestone marks a significant step in strengthening the global intellectual property portfolio of the RenMice® fully human antibody platform family. It underscores the continued advancement of Biocy
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biocytogen
Sign Up For FreeTo access detailed company insights
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is a global biotechnology company that drives the research and development of novel antibody-based therapeutics. The company has streamlined the drug development process through the use of RenMice for fully human antibody discovery, in vivo drug efficacy screening platforms and strong clinical developm... Read More
